 |
|
Key component of debilitating lung disease identified
September 12, 2008For the first time, researchers have demonstrated a close correlation between the decline in a key component of the lung's antioxidant defense system and the progression of chronic obstructive pulmonary disease (COPD) in humans. COPD is a degenerative condition that decreases the flow of air through the lungs as the lung's air sacs are damaged. A study of lung tissue samples from COPD patients by scientists at the Johns Hopkins Bloomberg School of Public Health found that expression of the regulating gene NRF2 was significantly decreased in smokers with advanced COPD compared to smokers without COPD. The study is published in the September 15, 2008, edition of the American Journal of Respiratory and Critical Care Medicine.
The study team was led by Shyam Biswal, PhD, an associate professor in the Bloomberg School's Department of Environmental Health Sciences and the Division of Pulmonary and Critical Care Medicine at the Johns Hopkins School of Medicine. According to Biswal, NRF2 (nuclear factor erythroid-derived 2-related factor 2) works as a "master gene" to turn on numerous antioxidant and pollutant-detoxifying genes to protect the lungs from environmental pollutants, such as cigarette smoke. Biswal previously identified that disruption of NRF2 expression in mice caused early onset and severe emphysema, which is a major component of COPD in human. However, the status of this critical pathway in humans with COPD was unclear.
"This work clearly demonstrates that decline in our antioxidant system is involved in progression of COPD, which could also be the case for other environmental diseases," said Biswal. "There is no treatment of COPD, but NRF2 could be a novel target for the development of new drug therapies."
Rubin Tuder, MD, a co-author of the study now with the faculty of the University of Colorado, added, "As we learn how the protective actions of NRF2 are decreased in the course of a lifetime of exposure to cigarette smoke, it opens new venues for the development of novel drugs fitted for individual patients in specific stages of the disease."
The research was supported by the National Institutes of Health through an investigator- initiated grant, as well as the Specialized Center for Clinically Oriented Research (SCCOR) at the Johns Hopkins School of Medicine. Lung specimens were provided by the Lung Tissue Research Consortium, which is supported by the National Heart, Lung and Blood Institute.
"COPD affects more than 16 million Americans and is the fourth highest cause of death in the United States," said Robert Wise, MD, professor at the Johns Hopkins School of Medicine and director of the Hopkins SCCOR initiative. "It is the only disease among the top 10 causes of death with a rising mortality rate in the United States. It is predicted to be the third largest cause of death by 2020 and has already reached worldwide epidemic proportions."
Johns Hopkins University Bloomberg School of Public Health
Rubin Tuder, MD, a co-author of the study now with the faculty of the University of Colorado, added, "As we learn how the protective actions of NRF2 are decreased in the course of a lifetime of exposure to cigarette smoke, it opens new venues for the development of novel drugs fitted for individual patients in specific stages of the disease."
The research was supported by the National Institutes of Health through an investigator- initiated grant, as well as the Specialized Center for Clinically Oriented Research (SCCOR) at the Johns Hopkins School of Medicine. Lung specimens were provided by the Lung Tissue Research Consortium, which is supported by the National Heart, Lung and Blood Institute.
"COPD affects more than 16 million Americans and is the fourth highest cause of death in the United States," said Robert Wise, MD, professor at the Johns Hopkins School of Medicine and director of the Hopkins SCCOR initiative. "It is the only disease among the top 10 causes of death with a rising mortality rate in the United States. It is predicted to be the third largest cause of death by 2020 and has already reached worldwide epidemic proportions."
Johns Hopkins University Bloomberg School of Public Health
Chronic Obstructive Pulmonary Disease Current Events and Chronic Obstructive Pulmonary Disease News RSSLong-term antibiotics reduce COPD exacerbations, raise questions
Long-term use of a macrolide antibiotic may reduce the frequency of exacerbations in patients with moderate to severe chronic obstructive pulmonary disease (COPD) by as much as 35 percent, according to a London-based study.
Hospital visits for respiratory illnesses spiked during Southern California wildfires
Raging wildfires that engulfed Southern California earlier this decade not only destroyed neighborhoods laying in their path, they also caused significant health problems for many who lived outside the fires' reach.
Cold virus found to manipulate genes
Sneezing, runny nose and chills? You might blame the human rhinovirus (HRV), which causes 30 to 50 percent of common colds. But in reality, it's not the virus itself but HRV's ability to manipulate your genes that is the true cause of some of the most annoying cold symptoms.
Depression may increase exacerbations, hospitalizations in COPD
It is well known that patients with chronic obstructive pulmonary disease (COPD) frequently suffer from depression and anxiety, but according to new research, depression and anxiety may actually cause increased hospitalizations and exacerbations.
First comprehensive genomic study of common cold reveals new treatment targets
Today, scientists from Procter & Gamble (P&G), the University of Calgary and the University of Virginia announced results from the first study to examine the entire human genome's response to the most common cold virus, human rhinovirus.
UCSF Fresno leading-edge study lends hope to emphysema patients
Patients in the Valley with emphysema might soon be breathing a little easier thanks to a new airway bypass study called the Exhale Airways Stents for Emphysema (EASE) trial.
RSV may hide in the lungs, lead to asthma, UT Southwestern researchers report
Conventional wisdom has been that respiratory syncytial virus (RSV) - a common virus that causes infection in the lungs - comes and goes in children without any long lasting impact.
Stress tests to confirm need for cardiac stent not occurring in most patients, new study finds
UCSF researchers investigating the appropriate use of procedures to open narrowed coronary arteries -- such as angioplasty and stenting -- found that less than half of Medicare patients had documented noninvasive stress testing prior to elective percutaneous coronary intervention, or PCI, the clinical name for such procedures.
Death rate 70 percent lower at top-rated hospitals: HealthGrades annual hospital quality study
Patients have on average a 70 percent lower chance of dying at the nation's top-rated hospitals compared with the lowest-rated hospitals across 17 procedures and conditions analyzed in the eleventh annual HealthGrades Hospital Quality in America Study, issued today by HealthGrades, the leading independent healthcare ratings organization.
Red wine may lower lung cancer risk
Moderate consumption of red wine may decrease the risk of lung cancer in men, according to a report in the October issue of Cancer Epidemiology, Biomarkers & Prevention¸ a journal of the American Association for Cancer Research.
More Chronic Obstructive Pulmonary Disease Current Events and Chronic Obstructive Pulmonary Disease News Articles
 | Long-Term Intervention in Chronic Obstructive Pulmonary Disease (Lung Biology in Health and Disease) Reviewing current strategies and methods to treat and manage patients suffering with ventilatory dysfunction, this reference provides a critical overview of the epidemiology, pathophysiology, diagnosis, and outcomes of COPD-describing techniques to prevent and reduce the development of symptoms, improve patient quality of life, and slow the progression of... |
 | Chronic Obstructive Pulmonary Disease Exacerbations (Lung Biology in Health and Disease) Exacerbations of Chronic Obstructive Pulmonary Disease (COPD) covers the definition, diagnosis, epidemiology, mechanisms, and treatment associated with COPD exacerbations. This text also addresses imaging, and how it plays a pivotal role in the diagnosis and study of exacerbations. Written by today’s top experts, Exacerbations of Chronic Obstructive Pulmonary Disease... |
 | Managing Chronic Obstructive Pulmonary Disease Chronic Obstructive Pulmonary Disease (COPD) is increasing rapidly worldwide and it's predicted that by 2020 it will represent the third leading cause of death. Sadly, this slow-progressing debilitating disease not only affects the individual but also has consequences for the family. More positively, the urgent need to improve the care offered and to raise the public profile of the condition has... |
 | Acute Exacerbations of Chronic Obstructive Pulmonary Disease (Lung Biology in Health and Disease) Aids practitioners who are looking to more effectively diagnose, treat, and manage patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Discusses pulmonary gas exchange, muscle function and breathing, water/electrolyte imbalances, and end stage disease in... |
 | Handbook of Chronic Obstructive Pulmonary Disease by P John Rees, Peter M. A. Calverley Guy's Hospital, London, UK. Pocket text provides a definition of the disease and examines its pathology, diagnosis, and prevention. For residents, hospital physicians, and general practitioners. Two-tone format.... |
 | Chronic Obstructive Pulmonary Disease in Primary Care by Margaret Barnett Until recently COPD was largely neglected by health professionals and viewed as the Cinderella of respiratory conditions. Many patients were seen as heart-sink cases with a self-inflicted disease. But views are now changing and COPD, like other chronic conditions managed within primary care, has taken on a higher profile within the Government and NHS agenda. This book reflects that change. It... |
 | Clinical Management of Chronic Obstructive Pulmonary Disease (Lung Biology in Health and Disease) by SimiloWski/Whit Groupe Hospitalier Pitie-Salpetriere, Paris, France. Presents a comprehensive review of the most recent strategies used to assess, treat, and manage patients in each phase of chronic obstructive pulmonary... |
 | 21st Century Complete Medical Guide to Chronic Obstructive Pulmonary Disease (COPD) and Emphysema, Authoritative Government Documents, Clinical References, ... for Patients and Physicians (CD-ROM) by PM Medical Health News This up-to-date electronic book on CD-ROM provides the best collection available anywhere of official Federal government information and documents on the subject of COPD (Chronic Obstructive Pulmonary Disease) and emphysema. This CD-ROM uses next-generation search technology that allows complete indexing and makes all files on the disc fully searchable. For patients, practical information is... |
 | Emphysema And Chronic Obstructive Pulmonary Disease: Therapeutic Approaches Through Nutrition Natural Medicine Alternative Medicine by Robert J. Green In this defining and seminal work, Robert Green Jr., N.D. presents the first book ever to take an in depth look at the therapeutic approaches based on nutrition, natural medicine, and alternative medicine that are capable of improving the health and condition of people living with emphysema/COPD. This book, written primarily for individuals who have been diagnosed by a physician with emphysema... |
| Update on chronic obstructive pulmonary disease.(Clinical Practice): An article from: MedSurg Nursing by Anne H. Boyle, Dianne L. Locke This digital document is an article from MedSurg Nursing, published by Jannetti Publications, Inc. on February 1, 2004. The length of the article is 6305 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.From the author: ... |
| © 2008 BrightSurf.com |